Patented Medicine Prices Review Board annual report : H78
An independent, quasi-judicial body, Canada’s Patented Medicine Prices Review Board (PMPRB) regulates the prices of prescription and non-prescription patented drugs for human and veterinary use, ensuring that these prices are not excessive. This report includes a review of the PMPRB’s major activities, as well as analyses of the prices of patented medicines and of the price trends of all drugs. It also lists the R&D expenditures reported by patent-holding drug manufacturers.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.512094&sl=0
| Department/Agency | Canada. Patented Medicine Prices Review Board. |
|---|---|
| Title | Patented Medicine Prices Review Board annual report |
| Publication type | Series |
| Language | Bilingual-[English | French] |
| Format | Paper |
| Other formats | Electronic-[English] |
| Publishing information | Ottawa - Ontario : Patented Medicine Prices Review Board |
| Chronology | 1989-- |
| Frequency | Annual |
| ISSN | 0847-4397 |
| Catalogue number |
|
| Subject terms | Drugs Prices |
| Issues | 2010: 2009: |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: